We are updating our Privacy Policy and Terms and Conditions to help you clearly understand how your personal information is collected, stored and managed. Learn More
Menu Back to Event-Details

Collaboration across Decision Makers to Facilitate Patient Access: Recent Advances and Future Needs

Track:
Can Regulators and HTA Bodies Create Synergies for Patient Access?

Day & Time:
April 18, 10:30AM - 12:00PM (Central Europe Standard Time)

Session Number:
S0101

Room Number:
Singapore

Type:
Session

Title:
Collaboration across Decision Makers to Facilitate Patient Access: Recent Advances and Future Needs

Chair(s):
Michael Berntgen, PhD
Head of Product Development Scientific Support Department
European Medicines Agency, European Union, United Kingdom

Description:
Collaboration across Decision Makers to Facilitate Patient Access: Recent Advances and Future Needs

Presentation(s) & Speaker(s):
Panel Discussion
Daniel O'Connor, DrMed, PhD, MS
Medical Assessor
Medicines and Healthcare products Regulatory Agency, United Kingdom

Panel Discussion
Gesa Pellier, MD
Head Global Patient Access
Novartis Pharma AG, Switzerland

Panel Discussion
Donald Singer, MD, FRCP
Executive Committee
EACPT, United Kingdom

Panel Discussion
Peter Mol, PhD, RPh
Principal Clinical Assessor
College ter Beoordeling van Geneesmiddelen - Groningen, Netherlands

Panel Discussion
Deborah Morrison
Senior Scientific Adviser
National Institute for Health and Care Excellence (NICE), United Kingdom

Panel Discussion
Ad Schuurman, MBA, MSc
Head of the Business Contact Centre & International Affairs
National Health Care Institute (ZIN), Netherlands